New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
16:38 EDTCRUS, TZOO, NFLX, UA, NOK, AAPL, SWFT, BMYOn The Fly: Closing Wrap
Stocks on Wall Street were mixed as the Dow gained on the session, but Apple's (AAPL) steep post-earnings decline weighed on the Nasdaq. Among notable companies reporting earnings after tonight's close are Dow members Microsoft (MSFT) and AT&T (T)... ECONOMIC EVENTS: In the U.S., weekly jobless claims fell 5K to a seasonally adjusted 330K, which was below expectations for 360K. Markit's Flash U.S. Purchasing Managers’ Index jumped to 56.1 in January from the 54.0 final print for December. The leading indicators increased 0.5% to 93.9 in December, versus an expected increase of 0.4%. In Europe, the composite euro zone Purchasing Managers’ Index rose to 48.2 in January from 47.2 in December, beating expectations. In China, HSBC's flash PMI rose to 51.9 in January, slightly beating expectations for a 51.7 reading... COMPANY NEWS: The world's most valuable company, Apple, disappointed investors with its quarterly report and shares were punished through the session, closing down $63.51, or 12.35%, to $450.50. Despite earnings that beat consensus, Apple's revenue and iPhone sales fell short of expectations and the company said on its conference call that it is changing its approach to guidance, admitting it had been intentionally conservative in the past... Netflix (NFLX) shares were up $43.60, or 42.22%, to $146.86 after the company reported a profitable quarter when a loss was expected... Among large cap companies reporting results Bristol-Myers (BMY) gained 91c, or 2.61%, to $35.81 while Nokia (NOK) lost 38c, or 8.19%, to $4.26... MAJOR MOVERS: Among the notable gainers were Travelzoo (TZOO), up $4.67, or 24.31%, to $23.88, and Swift Transportation (SWFT), up $2.91, or 28.45%, to $13.14 after both companies beat earnings expectations. Among noteworthy losers was Under Armour (UA), down $1.83, or 3.84%, to $45.86 after the company's footwear VP announced his resignation. Also lower were shares of Cirrus Logic (CRUS), down $3.24, or 10.82%, to $26.71 the day after Apple's earnings report and ahead of Cirrus' own report, which came after today's closing bell... INDICES: The Dow was up 46.00, or 0.33%, to 13,825.33; the Nasdaq was down 23.29, or 0.74%, to 3,130.38; and the S&P 500 was virtually unchanged, rising 0.01 to 1,494.82.
News For AAPL;NFLX;BMY;NOK;TZOO;SWFT;UA;CRUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
December 9, 2014
11:29 EDTNFLXDiscovery CEO says international market 'steady, good' for company
Subscribe for More Information
10:35 EDTAAPLApple falls, levels to watch
Subscribe for More Information
10:32 EDTNFLXNetflix hits a fresh 6-month low, levels to watch
Subscribe for More Information
09:38 EDTAAPLActive equity options trading
Subscribe for More Information
09:21 EDTAAPLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: AutoZone (AZO), up 3.8%... Burlington Stores (BURL), up 3.3%. ALSO HIGHER: bluebird bio (BLUE), up 56.5% after price target raised at Piper Jaffray and SunTrust... Camtek (CAMT), up 6.7% after being awarded a $2.8M order from a semiconductor manufacturer... PDC Energy (PDCE), up 5.8% after providing fiscal 2015 production guidance... Mast Therapeutics (MSTX), up 3.1% after reporting that it will begin recruiting patients for MST-188 study in first half of fiscal 2015... Idera Pharmaceuticals (IDRA), up 1.4% after announcing data for its lead product candidate, IMO-8400. DOWN AFTER EARNINGS: UTi Worldwide (UTIW), down 10.8%... CONN'S (CONN), down 35.9% after reporting third quarter results, withdrawing fiscal 2015 guidance, stating that there is no timetable set for completion of strategic alternatives, and announcing the departure of its CFO. ALSO LOWER: Apple (AAPL), down 1.6% after Pacific Crest says that weak iPad demand could cause Apple to miss estimates and following a Wall Street Journal report that a judge denied Apple's efforts to throw out iPod pricing lawsuit... Allied Nevada Gold (ANV), down 30.1% after announcing pricing of common stock and warrant offering... United Continental (UAL), down 2.7% after reporting November traffic.
08:25 EDTBMYBristol-Myers data positive, says BMO Capital
Subscribe for More Information
08:03 EDTAAPLWeak iPad demand could cause Apple to miss estimates, says Pacific Crest
Subscribe for More Information
06:48 EDTNFLXNetflix wants to be 'completely global' within five years, GigaOM reports
Netflix Chief Content Officer Ted Sarandos told investors at the UBS Global Media and Communications Conference that the company wants to be "completely global" and available everywhere in the world before 2020, GigaOM reports. CEO Reed Hastings has previously said that the company could eventually generate up to 80% of its revenue outside the U.S. Reference Link
06:20 EDTAAPLJudge denies Apple's efforts to throw out iPod pricing suit, WSJ reports
Subscribe for More Information
December 8, 2014
16:00 EDTAAPLOptions Update; December 8, 2014
Subscribe for More Information
13:32 EDTBMYPfizer, Bristol-Myers announce results of human study on Eliquis
Bristol-Myers Squibb Company (BMY) and Pfizer (PFE) announced results of the first human study evaluating the reversal of the anticoagulant effect of Eliquis by 4-factor prothrombin complex concentrates in healthy subjects. The study results demonstrated that both PCCs, Sanquin’s Cofact and CSL Behring’s Beriplex P/N reversed the steady-state pharmacodynamic effects of Eliquis in several coagulation assessments, including endogenous thrombin potential. The full data will be presented today during the Antithrombotic Therapy: Anticoagulant Therapy session at the 56th annual meeting of the American Society of Hematology in San Francisco, CA. The study was an open label, randomized, placebo-controlled, three-period crossover study in 15 healthy, adult subjects. Within each period, subjects received Eliquis 10 mg twice daily. On day four, three hours after Eliquis administration, subjects received a 30-minute infusion of 4-factor PCCs, either 50 IU/kg Cofact or Beriplex P/N, or an equivalent volume of saline solution. The effect of Cofact and Beriplex P/N on the pharmacodynamics of Eliquis was based upon changes in endogenous thrombin potential, a measure of thrombin-mediated coagulation. Treatment periods were separated by an 11-day washout, after which the alternate treatment was administered. In this study, no serious adverse events, bleeding-related events or signs of thrombosis were reported with Eliquis administration with or without PCC treatment. Overall, these data demonstrate that Cofact and Beriplex P/N reversed the steady-state pharmacodynamic effects of Eliquis as measured by ETP and support further evaluation of PCCs in the management of patients treated with Eliquis who require reversal of its anticoagulant effect.
13:16 EDTAAPLApple trades off session lows, levels to watch
Subscribe for More Information
11:29 EDTNFLXNetflix falls to session lows, levels to watch
The shares are down over 2% to $342.44. At that price next support is at $340.05. Resistance is at $345.45.
10:00 EDTNFLXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:37 EDTAAPLApple rumored to be launching 4-inch iPhone in 2015, Times of India reports
Apple is rumored to be developing a new iPhone with a 4-inch display, The Times of India reports, citing a report from The Electronic Times of Taiwan. According to supply chain sources, the device will launch in 2H15. Reference Link
06:22 EDTAAPLApple price target raised to $135 from $120 at Citigroup
Citigroup raised its earnings estimates for Apple after its field work indicated consumers are increasingly buying the higher memory iPhone 6 and 6+. Citi expects purchasing trends towards higher memory devices to drive stronger sales and margins. It believes consensus estimates are yet to factor in this development. The firm raised its price target for Apple shares to $135 from $120 and keeps a Buy rating on the name. Shares of phone maker closed Friday down 49c to $115.
06:15 EDTAAPLLenovo shipments expected to lead Samsung by 9M in 2015, DigiTimes reports
Lenovo (LNVGY) is estimated to beat Samsung (SSNLF) in mobile device shipments in 2015 by about 9M units, reports DigiTimes Research. Lenovo is set to beat Samsung by about 1M units in 2014 and become the second largest mobile computing device brand vendor worldwide behind Apple (AAPL). DigiTimes Research says Lenovo and Samsung plan to focus on maintaining tablet shipments as demand weakens in 2015. Reference Link
05:53 EDTBMYStocks with implied volatility movement; BSX BMY
Subscribe for More Information
December 7, 2014
14:10 EDTBMYAmerican Society of Hematology to hold a meeting
Subscribe for More Information
13:06 EDTBMYBMY announces positive results in Phase 1b trial evaluating Opdivo
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use